REGISTERED NUMBER: 02896614 (England and Wales)

Financial Statements

for the Year Ended 31 March 2025

for

Thames Medical Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

M W Brampton

Dr M Anderson

REGISTERED OFFICE:

Unit 4

Merlin Way

Bowerhill Industrial Estate

Melksham

Wiltshire

SN12 6TJ

REGISTERED NUMBER:

02896614 (England and Wales)

ACCOUNTANTS:

Mander Duffill

Chartered Accountants

The Old Post Office

41-43 Market Place

Chippenham

Wiltshire

SN15 3HR

FIXED ASSETS

Intangible assets

4

-

-

Tangible assets

5

46,694

58,368

46,694

58,368

CURRENT ASSETS

Stocks

110,520

92,297

Debtors

6

27,972

21,288

Cash at bank

33,263

7,341

171,755

120,926

CREDITORS

Amounts falling due within one year

7

267,768

77,543

NET CURRENT (LIABILITIES)/ASSETS

(96,013

)

43,383

TOTAL ASSETS LESS CURRENT LIABILITIES

(49,319

)

101,751

CREDITORS

Amounts falling due after more than one year

8

-

(11,798

)

PROVISIONS FOR LIABILITIES

(11,674

)

(14,592

)

NET (LIABILITIES)/ASSETS

(60,993

)

75,361

CAPITAL AND RESERVES

Called up share capital

125

125

Retained earnings

(61,118

)

75,236

SHAREHOLDERS' FUNDS

(60,993

)

75,361

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 November 2025 and were signed on its behalf by:

Dr M Anderson - Director

1.	STATUTORY INFORMATION

Thames Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Plant and machinery etc

-

20% on reducing balance

Stocks

Stocks have been valued at the lower of cost and estimated selling price less costs to sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacture or completion.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

Goodwill

assets

Totals

£

£

£

COST

At 1 April 2024

and 31 March 2025

695

400

1,095

AMORTISATION

At 1 April 2024

and 31 March 2025

695

400

1,095

NET BOOK VALUE

At 31 March 2025

-

-

-

At 31 March 2024

-

-

-

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2024

and 31 March 2025

159,550

DEPRECIATION

At 1 April 2024

101,182

Charge for year

11,674

At 31 March 2025

112,856

NET BOOK VALUE

At 31 March 2025

46,694

At 31 March 2024

58,368

Fixed assets, included in the above, which are held under hire purchase contracts or finance leases are as follows:

Plant and

machinery

etc

£

COST

At 1 April 2024

and 31 March 2025

43,601

DEPRECIATION

At 1 April 2024

21,277

Charge for year

4,465

At 31 March 2025

25,742

NET BOOK VALUE

At 31 March 2025

17,859

At 31 March 2024

22,324

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade debtors

25,983

19,340

Other debtors

1,989

1,948

27,972

21,288

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade creditors

28,807

16,288

Other creditors

238,961

61,255

267,768

77,543

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.25

31.3.24

£

£

Other creditors

-

11,798

9.	ULTIMATE CONTROLLING PARTY

The controlling party is Genesis Industries Europe Limited.

The registered office of Genesis Industries Europe Limited is Unit 4, Merlin Way, Bowerhill Industrial Estate, Melksham, Wiltshire SN12 6TJ.